Co-Founder | Research Lead
Psychedelics & Pain Association (PPA)
Astoria, New York
A former chronic pain sufferer, Court Wing is founder & CEO of REMAP Therapeutics and co-founder of the Psychedelics & Pain Association (PPA).
In 2020, Court was a study participant in NYU’s clinical trial of Psilocybin for Major Depressive Disorder. By the end of his “dosing” day in the trial, he was in full remission. More astonishing, he was also no longer suffering low-to-moderate chronic pain. With his extensive experience in applied neurophysiology for pain & performance of over 30 years, he immediately realized psychedelics were going to completely change the way we are able to treat chronic pain.
Disclosure information not submitted.
PSD-02 - Real World Evidence on Psychedelics for Pain - Patient Perspectives
Wednesday, September 4, 2024
9:40 AM – 10:30 AM PST
PSD-05 - Q&A on the Future of Psychedelic Medicine
Friday, September 6, 2024
11:00 AM – 11:50 AM PST